伊拉克免疫接种不良事件监测进展:CIVIE项目2022-2023年洞见
该研究描述伊拉克通过CIVIE项目在2022至2023年间将AEFI报告从纸质转为电子、培训超2250名医务人员并引入强化被动监测,使报告病例从2022年17320例增至2023年510702例,但严重事件仍被低估。
要点
- 电子报告与培训使AEFI报告量从2022年17320例增至2023年510702例。
- 2023年99.93%报告病例为轻微AEFI,严重事件仍报告不足。
- 五价疫苗关联的AEFI百分比最高,但原文未给具体数值。
核心结论
- 数字化转换和能力建设显著提升了伊拉克AEFI监测的报告量。
- 严重AEFI报告不足、地区差异和医院监测有限仍是持续挑战。
研究设计与样本
- 描述性横断面研究,使用伊拉克扩大免疫规划及相关报告的二手数据。
- 干预包括从纸质转向电子报告、培训超2250名医务人员和引入强化被动监测。
主要发现
- 2023年记录510702例AEFI,2022年仅17320例。
- 2023年轻微AEFI占报告总病例的99.93%。
- 五价疫苗关联的AEFI百分比最高。
- 严重事件仍报告不足,地区报告差异持续存在。
临床怎么用
- 将AEFI报告整合到所有医疗机构并加强基于病例的监测。
- 扩大医院哨点监测并确保持续 workforce 培训以维持改进。
局限性
- 使用二手数据,可能存在报告偏倚和信息不完整。
- 严重AEFI报告不足可能影响安全性信号检测。
- 地区报告差异和医院监测有限限制数据代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adverse Events Following Immunization (AEFI) surveillance is crucial for ensuring vaccine safety and maintaining public trust. In Iraq, AEFI monitoring faced limitations for years due to a paper-based reporting system, low reporting rates and inadequate data management. This study describes the advancements in AEFI surveillance implemented through the COVID-19 International Vaccine Implementation and Evaluation (CIVIE) project between 2022 and 2023 and the effects on acute events monitoring. A descriptive cross-sectional study was conducted using secondary data from Iraq's Expanded Program on Immunization and related reports. Key interventions included transitioning from paper-based to electronic reporting, training over 2250 healthcare workers and introducing enhanced passive surveillance. These measures led to a significant increase in AEFI reporting, with 510,702 cases documented in 2023, compared to only 17,320 in 2022. Minor AEFIs constituted 99.93 % of the total reported cases in 2023, while serious events remained underreported. The pentavalent vaccine was associated with the highest percentage of AEFIs. Despite the notable improvements, challenges such as regional disparities in reporting and limited hospital-based AEFI surveillance persist. The study highlights the impact of digital transformation and capacity building on vaccine safety monitoring. Further efforts are needed to integrate AEFI reporting into all healthcare settings, enhance case-based monitoring, and strengthen national immunization data systems to align with global standards. Expanding sentinel sites in hospitals and ensuring continuous workforce training will be critical for sustaining improvements in Iraq's vaccine safety surveillance system.
引用
- Jabbar F, Kadhim KA, Alhilfi RA, et al. Advancements in monitoring adverse events following immunization in Iraq: Insights from the CIVIE project 2022-2023. Vaccine. 2025. PMID: 41418610. doi:10.1016/j.vaccine.2025.128121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。